Join to View Full Profile
3900 Woodland AvePhiladelphia, PA 19104
Phone+1 215-823-5800
Are you Dr. Schacter?
Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.
- Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Summary
- Dr. Lee Schacter, MD is an oncologist in Philadelphia, Pennsylvania. He is currently licensed to practice medicine in Delaware, Connecticut, and New York. He is an Executive Medical Director at Clinipace.
Education & Training
Cleveland Clinic FoundationFellowship, Hematology and Medical Oncology, 1978 - 1979- Cleveland Clinic FoundationResidency, Internal Medicine, 1976 - 1978
Johns Hopkins UniversityFellowship, Hematology and Medical Oncology, 1974 - 1976- Johns Hopkins University/Bayview Medical CenterResidency, Internal Medicine, 1973 - 1973
University of Miami Leonard M. Miller School of MedicineClass of 1973
Certifications & Licensure
NY State Medical License 1984 - 2025
CT State Medical License 1986 - 2024
DE State Medical License 2001 - 2017
MD State Medical License 1974 - 1991
OH State Medical License 1977 - 1986
American Board of Internal Medicine Internal Medicine- American Board of Internal Medicine Medical Oncology
Publications & Presentations
PubMed
- 34 citationsDHA-Paclitaxel (Taxoprexin) as First-Line Treatment in Patients with Stage IIIB or IV Non-small Cell Lung Cancer: Report of a Phase II Open-Label Multicenter TrialMiranda Payne, Paul Ellis, D. Dunlop, Malcolm R Ranson, Sarah Danson
Journal of Thoracic Oncology. 2006-11-01 - 12 citationsPharmacokinetic evaluation of high-dose etoposide phosphate after a 2-hour infusion in patients with solid tumorsWilli Kreis, Daniel R. Budman, Vincent Vinciguerra, Kathleen Hock, Joann Baer
Cancer Chemotherapy and Pharmacology. 1996-01-01 - 7 citationsPhase II study of elsamitrucin (BMY-28090) for the treatment of patients with refractory/relapsed non-Hodgkin's lymphoma*Steven L. Allen, Lee P. Schacter, Stuart M. Lichtman, Ronald M. Bukowski, D. Fusco
Investigational New Drugs. 1996-01-01
